Innovative Immunodiagnostic Platform Unveils Highly Sensitive Cancer Early-Detection Test with Predictive Treatment Insights

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

Proteotype-Breakthru

More Like This

PR Newswire associated0

Proteotype Awarded £1.5 Million Grant to Advance Early Cancer Detection with Innovative Enlighten® Test

PR Newswire associated0

Proteotype Diagnostics Selected for EU-Funded HER-CARE Doctoral Network, Signalling Growing Research Leadership in Precision Oncology

PR Newswire associated0

Trial Evaluating Blood Test for 10 Cancers Reaches Major Milestone

Immunovia successfully develops assays to measure targeted proteins for its next-generation pancreatic cancer test - moving forward towards model-development study

Immunovia successfully completes discovery phase of next-generation test development

PR Newswire associated0

Sengenics Corporation Unveils i-Ome® Cancer: A Breakthrough in Cancer Precision Medicine

PR Newswire associated0

Kinomica Announces Multiple Abstracts on its KScan® Precision Oncology Diagnostic Platform to be Presented at the 72nd Annual Meeting of the American Society for Mass Spectrometry

Proteintech Genomics' MultiPro™ Human Fixed Cell Immune Profiling Antibody Cocktail containing 53 antibodies against intracellular and cell surface proteins, plus 5 isotype controls (Photo: Business Wire)

Proteintech Genomics Launches First Commercially Available Solution for the Detection of Intracellular Proteins for Single-Cell RNAseq Experiments